Join to view full profile
400 E 3rd StDuluth, MN 55805
Phone+1 218-786-8364
Fax+1 952-442-8055
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Brian Moran, MD is a board certified neurologist in Duluth, Minnesota. He is currently licensed to practice medicine in Minnesota. He is affiliated with Essentia Health St. Mary's Medical Center.
Education & Training
University of MinnesotaFellowship, Clinical Neurophysiology, 2013 - 2014- University of MinnesotaResidency, Neurology, 2009 - 2013
University of Nebraska College of MedicineClass of 2009
Certifications & Licensure
MN State Medical License 2014 - 2027
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Epilepsy
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
Publications & Presentations
PubMed
- 22 citationsInfantile Epileptic Encephalopathy Associated With SCN2A Mutation Responsive to Oral Mexiletine.Laura A. Foster, Maria R. Johnson, John T. MacDonald, Peter I. Karachunski, Thomas R. Henry
Pediatric Neurology. 2017-01-01 - 23 citationsSeizure outcomes of posterior reversible encephalopathy syndrome and correlations with electroencephalographic changesZhiyi Sha, Brian P. Moran, Alexander M. McKinney, Thomas R. Henry
Epilepsy & Behavior. 2015-07-01 - 20 citationsPosterior reversible encephalopathy syndrome induced by pazopanib for renal cell carcinoma.G. Asaithambi, B. R. Peters, Elisabeth Hurliman, B. P. Moran, Amir S. Khan
Journal of Clinical Pharmacy and Therapeutics. 2013-04-01
